FibroGen (NASDAQ: FGEN) reported Q1 EPS of ($0.81), $0.06 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $36.16 million versus the consensus estimate of $31.67 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.